Kalon Biological-B(06990) announced that the company has received a notice of record of the implementation of full circulation of H shares issued by the China Securities Regulatory Commission...
The company has received a notice of record on August 23, 2024 from the China Securities Regulatory Commission regarding the implementation of full circulation of H shares. The company has obtained the record of implementing full circulation of H shares for a total of 1.1578 million shares of domestic shares and non-listed foreign shares, and the company has received approval from the Stock Exchange for the conversion of H shares and permission for trading on September 3, 2024.
The conversion of H shares has been completed on September 17, 2024, and the trading of converted H shares will start at 9:00 am on September 19, 2024 on the Stock Exchange.
